Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal

id	metarevistapublica_fucsalud_revistarepertoriodemedicinaycirugia_98-article-1661
record_format	ojs
spelling	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal Márquez , Gloria Artículo de revista Núm. 2 , Año 2025 : mayo - agosto 2 34 Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud Revista Repertorio de Medicina y Cirugía Carvajal-Veloza, Jonathan Gutiérrez-Castañeda, Luz Dary Parra-Medina, Rafael Ramírez , Andrea Journal article Iakoubov R, Lauffer LM, Trivedi S, Kim YIJ, Brubaker PL. Carcinogenic Effects of Exogenous and Endogenous Glucagon-Like Peptide-2 in Azoxymethane-Treated Mice. Endocrinology. 2009;150(9):4033–43. https://doi.org/10.1210/en.2009-0295 Atlas de Proteínas Humanas [Internet]. Proteinatlas [cited 2022 Sep 26]. Available from: https://www.proteinatlas.org/ Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–102. https://doi.org/10.1093/nar/gkx247 Ring LL, Nerup N, Jeppesen PB, Svendsen LB, Achiam MP. Glucagon like peptide-2 and neoplasia; a systematic review. Expert Rev Gastroenterol Hepatol. 2018;12(3):257–64. https://doi.org/10.1080/17474124.2018.1417032 Burrin DG, Stoll B, Guan X, Cui L, Chang X, Holst JJ. Glucagon-Like Peptide 2 Dose-Dependently Activates Intestinal Cell Survival and Proliferation in Neonatal Piglets. Endocrinology. 2005;146(1):22–32. https://doi.org/10.1210/en.2004-1119 Rowland KJ, Brubaker PL. The “cryptic” mechanism of action of glucagon-like peptide-2. Am J Physiol - Gastrointest Liver Physiol. 2011;301(1):G1–8. https://doi.org/10.1152/ajpgi.00039.2011 Koehler JA, Harper W, Barnard M, Yusta B, Drucker DJ. Glucagon-like Peptide-2 Does Not Modify the Growth or Survival of Murine or Human Intestinal Tumor Cells. Cancer Res. 2008;68(19):7897. https://doi.org/10.1158/0008-5472.CAN-08-0029 Körner M, Rehmann R, Reubi JC. GLP-2 receptors in human disease: High expression in gastrointestinal stromal tumors and Crohn’s disease. Mol Cell Endocrinol. 2012;364(1–2):46–53. https://doi.org/10.1016/j.mce.2012.08.008 Pedersen J, Pedersen NB, Brix SW, Grunddal KV, Rosenkilde MM, Hartmann B, Ørskov C, Poulsen SS, Holst JJ. The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine. Peptides. 2015;67:20-8. https://doi.org/10.1016/j.peptides.2015.02.007 Thulesen J, Hartmann B, Hare KJ, Kissow H, Ørskov C, Holst JJ, et al. Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut. 2004;53(8):1145–50. https://doi.org/10.1136/gut.2003.035212 Lu Y, Kweon S-S, Tanikawa C, Jia W-H, Xiang Y-B, Cai Q, et al. Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer. Gastroenterology. 2019;156(5):1455–66. https://doi.org/10.1053/j.gastro.2018.11.066 Bengi G, Kayahan H, Akarsu M, Aysal A, Saǧol Ö, Meral M, et al. Does glucagon like peptide-2 receptor expression have any effect on the development of human colorectal cancer? Turk J Gastroenterol. 2011;22(4):388–94. https://doi.org/10.4318/tjg.2011.0243 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2886 Trivedi S, Wiber SC, El-Zimaity HM, Brubaker PL. Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer. Am J Physiol Gastrointest Liver Physiol. 2012;302:840–9. https://doi.org/10.1152/ajpgi.00505.2011 Shawe-Taylor M, Kumar JD, Holden W, Dodd S, Varga A, Giger O, et al. Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway. Peptides. 2017;91:49–57. https://doi.org/10.1016/j.peptides.2017.03.008 Tappenden KA, Edelman J, Joelsson B. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome. J Clin Gastroenterol. 2013;47(7):602–7. https://doi.org/10.1097/MCG.0b013e3182828f57 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2876 Ramírez-Perdomo A, Márquez-Barrios G, Gutiérrez-Castañeda LD, Parra-Medina R. Neuroendocrine peptides in the pathogenesis of colorectal carcinoma. Exp Oncol. 2023 Jun 26;45(1):3-16. https://doi.org/10.15407/exp-oncology.2023.01.003 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2903 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_2df8fbb1 http://purl.org/redcol/resource_type/ART info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Kannen V, Garcia SB, Stopper H, Waaga-Gasser AM. Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy? Pharmacol Ther. 2013;139(1):87–94. https://doi.org/10.1016/j.pharmthera.2013.04.007 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Parra-Medina R, Moreno-Lucero P, Jimenez-Moreno J, Parra-Morales AM, Romero-Rojas A. Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality? PLoS One. 2019;14(5):e0216647. https://doi.org/10.1371/journal.pone.0216647 application/pdf carcinoma colon receptor del péptido 2 glucagón péptido 2 carcinoma colon glucagon peptide 2 receptor 2025-05-15 17:55:08 2025-05-15 17:55:08 2025-05-15 text/html Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol. 2011;92(4):219-231. https://doi.org/10.1111/j.1365-2613.2011.00767.x text/xml 0121-7372 2462-991X https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1661 10.31260/RepertMedCir.01217372.1661 https://doi.org/10.31260/RepertMedCir.01217372.1661 https://creativecommons.org/licenses/by-nc-sa/4.0 Revista Repertorio de Medicina y Cirugía - 2025 169 176 Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. https://doi.org/10.3322/caac.21660 Baracaldo Ayala, RL, Peña Carvajalino LF, Gómez Rodríguez O, Nieto JFP, López Correa P, Medina RP. Características histopatológicas del carcinoma colorrectal con inestabilidad microsatelital (IMS). Repert Med Cir. 2020;29(1):32-40. https://doi.org/10.31260/RepertMedCir.v29.n1.2020.172 Publication
institution	FUNDACIÓN UNIVERSITARIA DE CIENCIA DE LA SALUD
thumbnail	https://nuevo.metarevistas.org/FUNDACIONUNIVERSITARIADECIENCIADELASALUD/logo.png
country_str	Colombia
collection	Revista Repertorio de Medicina y Cirugía
title	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
spellingShingle	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal Márquez , Gloria Carvajal-Veloza, Jonathan Gutiérrez-Castañeda, Luz Dary Parra-Medina, Rafael Ramírez , Andrea carcinoma colon receptor del péptido 2 glucagón péptido 2 carcinoma colon glucagon peptide 2 receptor
title_short	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
title_full	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
title_fullStr	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
title_full_unstemmed	Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
title_sort	determinación de la expresión de glp-2 y glp-2r en adenocarcinoma colorrectal
author	Márquez , Gloria Carvajal-Veloza, Jonathan Gutiérrez-Castañeda, Luz Dary Parra-Medina, Rafael Ramírez , Andrea
author_facet	Márquez , Gloria Carvajal-Veloza, Jonathan Gutiérrez-Castañeda, Luz Dary Parra-Medina, Rafael Ramírez , Andrea
topic	carcinoma colon receptor del péptido 2 glucagón péptido 2 carcinoma colon glucagon peptide 2 receptor
topic_facet	carcinoma colon receptor del péptido 2 glucagón péptido 2 carcinoma colon glucagon peptide 2 receptor
citationvolume	34
citationissue	2
citationedition	Núm. 2 , Año 2025 : mayo - agosto
publisher	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
ispartofjournal	Revista Repertorio de Medicina y Cirugía
source	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1661
language
format	Article
rights	info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. https://creativecommons.org/licenses/by-nc-sa/4.0 Revista Repertorio de Medicina y Cirugía - 2025
type_driver	info:eu-repo/semantics/article
type_coar	http://purl.org/coar/resource_type/c_6501
type_version	info:eu-repo/semantics/publishedVersion
type_coarversion	http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content	Text
publishDate	2025-05-15
date_accessioned	2025-05-15 17:55:08
date_available	2025-05-15 17:55:08
url	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1661
url_doi	https://doi.org/10.31260/RepertMedCir.01217372.1661
issn	0121-7372
eissn	2462-991X
doi	10.31260/RepertMedCir.01217372.1661
citationstartpage	169
citationendpage	176
url3_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2886
url2_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2876
url4_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1661/2903
_version_	1833615073876115456

Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal .

Código QR

Estadísticas y Métricas Alternativas

Títulos similares

Determinación de la expresión de GLP-2 y GLP-2R en adenocarcinoma colorrectal
.